The claim on the front
This page sets out rules and quotes sources. It does not reach a verdict, because reaching one would require authority we do not have and a ruling that does not exist.
The bottle reads CLINICAL MEMORY RESTORATION. The brief supplied to this site described the claims as “daily mental clarity, sustained energy, cognitive well-being”. Those are not the same claim.
FDA has not ruled on this phrase in anything we could open, and we will not pretend otherwise. What follows is the framework, the relevant quotations, and an honest account of what we were unable to find.
What is actually printed
Two images were supplied to this site, both marketing renders showing the front of the bottle. No back panel was supplied. Here is everything legible on them.
- Product name
- VapoCept
- Claim line
- CLINICAL MEMORY RESTORATION
- Sub-line
- FOCUS | CLARITY | ENERGY
- Count and class
- 30 CAPSULES · DIETARY SUPPLEMENT
- Mark
- a brain drawn as a circuit board, with a lit core
- Disclaimer
- not visible on either supplied image
- Asterisk on the claim
- none visible on either supplied image
- Back panel
- not supplied
What we cannot see
The last three rows matter. Neither supplied image shows the FDA disclaimer, neither shows an asterisk on the claim line that would link to one, and no back panel was supplied at all. We are not saying the disclaimer is missing from the product. We are saying it is missing from everything we were shown, and that a reader is entitled to know which of those two statements we are in a position to make.
This is the fifth label this editorial desk has assessed, and it carries the strongest claim of the five by a clear margin. The other four used the word “support”. This one uses “restoration”, and puts “clinical” in front of it.
The rule the claim lives under
A dietary supplement may carry a structure/function claim — a statement that a nutrient affects a structure or function of the body — without pre-market approval. It may not carry a disease claim, which is a statement that the product treats, prevents, cures or mitigates a disease.
The regulation defines a disease as “damage to an organ, part, structure, or system of the body such that it does not function properly … or a state of health leading to such dysfunctioning”, and then lists ten criteria under which a claim counts as a disease claim. The tenth is a catch-all: a claim that “otherwise suggests an effect on a disease or diseases”.
The regulation is explicit that context decides. FDA says it “will consider the context in which the claim is presented”, and one of the criteria covers the use of “pictures, vignettes, symbols, or other means” as well as words.
Three things this framework is not
It is not a pre-approval process. Nobody at FDA reads a label before it ships.
It is not a judgement about whether the product works. A compliant claim can be made for an ineffective product and an effective product can carry a badly drafted claim.
It is not something a website can adjudicate. We can show you the rule and the label. The reading is yours.
What FDA has said about memory claims
This is the part where the product is on firmer ground than a reader might expect, and it belongs near the top rather than buried.
FDA's Small Entity Compliance Guide on structure/function claims gives worked examples. Among the acceptable structure/function claims it lists: “mild memory loss associated with aging”. Among the disease claims it lists: “Alzheimer's disease or senile dementias in the elderly”.
The 2000 final rule is more direct still: “For example, a claim to improve memory or strength would be a permitted structure/function claim, unless disease treatment were implied.” And it confirms that “mild memory problems associated with aging … will not be treated as diseases under this provision”, while “uncommon or serious conditions like senile dementia … will continue to be treated as diseases”.
| Wording | How FDA's guidance treats it |
|---|---|
| “Supports memory” | Structure/function. Permitted |
| “Improves memory” | Structure/function, per the final rule, unless disease treatment is implied |
| “Mild memory loss associated with aging” | Named in the compliance guide as an acceptable structure/function claim |
| “Alzheimer's disease or senile dementias in the elderly” | Named in the compliance guide as a disease claim |
| “Clinical memory restoration” | Not addressed in anything we could find. See below |
Scroll this table sideways →
So a memory claim on a supplement is not inherently a problem. The category is permitted, FDA says so in writing, and anyone suggesting otherwise is overstating the rule.
The word “restoration”
FDA's compliance guide addresses adjectives directly, and the sentence is worth reproducing in full because it cuts both ways:
From the Small Entity Compliance Guide
“No specific adjectives constitute a disease claim. Therefore, words such as ‘restore,’ ‘support,’ ‘maintain,’ ‘raise,’ ‘lower,’ ‘promote,’ ‘regulate,’ or ‘stimulate’ might create an implied disease claim if, in the context they are used, they imply an effect on disease.”
Read the first sentence as carefully as the second. No adjective is automatically a disease claim. “Restore” is not on a forbidden list. It is on a list of words that might create an implied disease claim depending on context — alongside “support”, which appears on every supplement label in the country.
So what is the context here? The front of the bottle pairs “restoration” with “clinical”, over a sub-line reading “focus | clarity | energy”, with a brain mark and a lit core, in a category marketed to older adults. Whether that context implies an effect on disease is exactly the judgement FDA reserves to itself, and we are not going to make it on the agency's behalf.
What we could not verify, stated plainly
We searched for FDA material addressing “memory restoration”, “clinical memory restoration”, or a doctrine about claims to restore a lost function. We found none. The adjectives sentence above is the closest on-point language in anything we could open. Nobody should read this page as saying FDA has ruled on this phrase, because it has not, and a page that implied otherwise would be doing exactly what it criticises.
The word “clinical”
“Restoration” is an FDA question. “Clinical” is mostly an FTC one, and the FTC's position is easier to state.
The FTC's Health Products Compliance Guidance, published in 2022, sets out the rule for claims that reference a level of scientific support: “Marketers of health-related products must have at least the level of support that they claim to have.”
Its worked example is almost on the nose for this label. A sports drink website touts a “clinically tested ingredient”; the guidance says that phrase “implies not just that the ingredient was tested, but also that the test results prove a benefit”.
Applied here: the word “clinical” on the front of a bottle does work. It tells a buyer that clinical evidence exists for what is being claimed. That is a representation which has to be supported independently of whether the memory claim itself is permissible.
No trial of the finished VapoCept formula was supplied to this site, and we could not find one. What exists is published human research on four of the individual ingredients, at doses between roughly 10 and 60 times what this capsule delivers.
That is the whole of what we can say. Whether the manufacturer holds substantiation we have not seen is not something a website can determine, and it is a question a buyer is entitled to put directly to the order desk.
Substantiation, and who checks it
The most common misunderstanding in this category is that a claim on a supplement label has been reviewed by somebody. Here is the actual sequence.
The manufacturer must hold substantiation
FDA's guidance requires a manufacturer making a structure/function claim to have substantiation that the claim is truthful and not misleading. It adopts the FTC standard: competent and reliable scientific evidence.
The product goes on sale
No approval, no filing, no review. FDA's own consumer page states that it “does not approve dietary supplements before they are marketed”.
The manufacturer notifies FDA within 30 days
21 CFR 101.93(a)(1) requires notification no later than 30 days after first marketing. After, not before. The notification says a claim is being made; it is not an application.
The disclaimer goes on the label
The regulation sets the wording, requires it adjacent to the claim or linked by a symbol, and requires boldface type no smaller than one-sixteenth of an inch.
Nobody reads the substantiation unless something goes wrong
The guidance contains no requirement to file it. It sits with the firm. A buyer never sees it, and neither did we.
That is not a scandal; it is the framework Congress built in 1994, and it applies to every supplement on every shelf. It is worth understanding because it tells you exactly how much a claim on a label is worth as evidence: it is worth knowing that a company was willing to print it.
The disclaimer, and what it would have to look like
Since we could not find the disclaimer in either supplied image, it is worth setting out what the regulation actually requires, so a reader holding the bottle can check it themselves in about ten seconds.
- The wording, for one claim
- “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”
- The wording, for more than one
- The same sentence with “These statements have” in place of “This statement has”.
- Placement
- Adjacent to the claim with no intervening material, or linked to it with a symbol such as an asterisk that appears again beside the disclaimer. It must appear on each panel or page carrying such a statement.
- Prominence
- Boldface type, in letters no smaller than one-sixteenth of an inch, and set off in a box where it is not adjacent to the claim.
If you have a bottle, look at the back panel and look for an asterisk on the front. If both are there, the label is doing what the rule asks. If you find them, tell us through the editorial inbox and this section gets updated with the date.
This site carries the disclaimer
The footer of every page on this website carries the required wording, because this site discusses the product's claims and the same reasoning applies to us.
What the wider evidence says about memory supplements
A claim page owes the reader the broader picture, not just the regulatory mechanics.
The National Institute on Aging's consumer page on cognitive health states: “At this time, no vitamin or supplement is recommended for preventing Alzheimer's or other forms of cognitive decline.” NCCIH's review of the evidence is similar: “Although a few trials of natural products for the prevention of cognitive decline or dementia have shown some modest effects, direct evidence is lacking.”
Neither of those is about VapoCept specifically, and neither says supplements are useless. They say the evidence base for the category does not currently support prevention claims, which is a narrower and more useful statement than either the marketing or the sceptics usually manage.
The one real harm
Memory change that worries you deserves an assessment rather than a supplement. Thyroid function, B12 status, sleep apnoea, medication side effects, hearing loss and depression all present as memory complaints and all have treatments. A bottle bought instead of that conversation is the only way a product like this can do genuine damage.
What we would publish
- A trial of the finished formula, at any dose, with any result. It would lead this page.
- A photograph of the back panel showing the disclaimer and its placement.
- The substantiation file behind the front-of-bottle claim, or a summary of what is in it.
- An FDA or FTC communication about this label, in either direction.
- Confirmation of the exact claim wording on the current production run, if it differs from the images we were given.
All of it gets published with the date it arrived. Write to the editorial inbox or ring the order desk, both listed in the footer, Monday to Friday, 9:00am to 5:00pm Eastern Time.
What the formula delivers →The rules this site is written under →Our own disclaimer →
See the VapoCept packs
Two, three or six bottles, priced plainly, with a 60-day window that runs from purchase. Read the capsule count first, then decide.
Shipping is calculated at checkout. This site publishes no figure it was not given.
References
Every source below was opened and read during this build. Nothing here cites a study we did not read, and no identifier on this site was written from memory. Where a claim could not be verified, the page says so instead of using it.
- U.S. Government Publishing Office21 CFR 101.93 — Certain types of statements for dietary supplements — eCFR.gov · source
- U.S. Food and Drug AdministrationSmall Entity Compliance Guide on Structure/Function Claims — FDA.gov · source
- U.S. Food and Drug Administration — 2000Regulations on Statements Made for Dietary Supplements Concerning the Effect of the Product on the Structure or Function of the Body, final rule — 65 Federal Register 1000 · 65 FR 1000 · source
- U.S. Food and Drug AdministrationGuidance for Industry: Substantiation for Dietary Supplement Claims Made Under Section 403(r)(6) — FDA.gov · source
- U.S. Food and Drug AdministrationQuestions and Answers on Dietary Supplements — FDA.gov · source
- U.S. Federal Trade Commission — 2022Health Products Compliance Guidance — FTC.gov · source
- National Institute on AgingCognitive Health and Older Adults — NIA.NIH.gov · source
- National Center for Complementary and Integrative HealthDietary Supplements and Cognitive Function, Dementia, and Alzheimer’s Disease: What the Science Says — NCCIH.NIH.gov · source
- U.S. Food and Drug AdministrationDaily Value on the Nutrition and Supplement Facts Labels — FDA.gov · source
- NIH Office of Dietary SupplementsNiacin — Health Professional Fact Sheet — ods.od.nih.gov · source
- NIH Office of Dietary SupplementsCalcium — Health Professional Fact Sheet — ods.od.nih.gov · source
- Böger — 2007The Pharmacodynamics of L-Arginine — The Journal of Nutrition · DOI 10.1093/jn/137.6.1650S · source
- Shiraseb, Asbaghi, Bagheri, Wong, Figueroa, Mirzaei — 2022Effect of L-Arginine Supplementation on Blood Pressure in Adults: a systematic review and dose–response meta-analysis — Advances in Nutrition · DOI 10.1093/advances/nmab155 · PMID 34891179 · source
- Mone, Pansini, Jankauskas et al. — 2022L-Arginine Enhances the Effects of Cardiac Rehabilitation on Physical Performance: new insights for managing cardiovascular patients during the COVID-19 pandemic — Frontiers in Cardiovascular Medicine · DOI 10.3389/fcvm.2022.868521 · source
- Schwedhelm, Maas, Freese et al. — 2008Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism — British Journal of Clinical Pharmacology · DOI 10.1111/j.1365-2125.2007.02990.x · PMID 17662090 · source
- Campbell, Roberts, Kerksick et al. — 2006Pharmacokinetics, safety, and effects on exercise performance of L-arginine α-ketoglutarate in trained adult men — Nutrition, volume 22 · source
- National Library of MedicineL-Arginine alpha-ketoglutarate 2:1 — PubChem CID 76045315, formula C17H34N8O9 — PubChem · CID 76045315 · source
- Suzuki, Morita, Kamimura, Miyazawa — 2016Oral L-citrulline supplementation enhances cycling time trial performance in trained male cyclists — Journal of the International Society of Sports Nutrition · DOI 10.1186/s12970-016-0117-z · source
- Schierbauer et al. — 2025Effects of L-citrulline supplementation on exercise capacity in healthy young adults — Frontiers in Sports and Active Living · DOI 10.3389/fspor.2025.1627743 · source
- Gough, Sheeran, Shave, Waldron, Jeffries — 2021A critical review of citrulline malate supplementation and exercise performance — European Journal of Applied Physiology · DOI 10.1007/s00421-021-04774-6 · PMID 34417006 · source
- Trexler, Smith-Ryan, Stout et al. — 2015International Society of Sports Nutrition position stand: Beta-Alanine — Journal of the International Society of Sports Nutrition · DOI 10.1186/s12970-015-0090-y · PMID 26175657 · source
- Solis, Cooper, Hobson et al. — 2015Effects of beta-alanine supplementation on brain homocarnosine/carnosine signal and cognitive function: an exploratory study — PLOS ONE · DOI 10.1371/journal.pone.0123857 · PMID 25875656 · source
- Ostfeld, Ben-Zeev, Zamir et al. — 2023Effect of Beta-Alanine Supplementation on Cognitive Function in Older Adults — Nutrients, volume 15 · DOI 10.3390/nu15040923 · PMID 36839281 · source
- Shafqat — 2016The effect of L-citrulline supplementation on mood and cognition — a postgraduate thesis, not a peer-reviewed trial — Queen Margaret University eResearch · source
- Ambrogi et al. — 2023A New Challenge for the Old Excipient Calcium Carbonate — Pharmaceutics · DOI 10.3390/pharmaceutics15010300 · source
- National Institute of Standards and TechnologyArginine — C6H14N4O2, 174.2010 g/mol — NIST Chemistry WebBook · source
- National Institute of Standards and Technology2-Oxopentanedioic acid — C5H6O5, 146.0981 g/mol — NIST Chemistry WebBook · source
- National Institute of Standards and TechnologyCitrulline — C6H13N3O3, 175.1857 g/mol — NIST Chemistry WebBook · source
- National Institute of Standards and TechnologyHydrogen chloride — ClH, 36.461 g/mol — NIST Chemistry WebBook · source
- National Institute of Standards and TechnologyMalic acid — C4H6O5, 134.0874 g/mol — NIST Chemistry WebBook · source
- National Institute of Standards and Technologybeta-Alanine — C3H7NO2, 89.0932 g/mol — NIST Chemistry WebBook · source
Who made and checked this VapoCept page
Written from the seller’s panel, the front of the bottle and the sources cited on the page, then reviewed before publication. It is general information for adults and does not replace a conversation with your own clinician.
If your memory or concentration is changing, or you are on medicine for blood pressure or the heart, the first conversation is with your clinician, before the first VapoCept capsule.